Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson's Disease "Off" Episodes
Parkinson's Disease (PD) is a common neurodegenerative disorder and the leading cause of disability. It causes significant morbidity and disability through a plethora of symptoms, including movement disorders, sleep disturbances, and cognitive and psychiatric symptoms. The traditional pathogene...
Saved in:
Main Authors: | Amnon A. Berger, Ariel Winnick, Jonathan Izygon, Binil M. Jacob, Jessica S. Kaye, Rachel J. Kaye, Elisa E. Neuchat, Adam M. Kaye, Edward S. Alpaugh, Elyse M. Cornett, Andrew H. Han, Alan D. Kaye |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Medical Publishing
2022-06-01
|
Series: | Health Psychology Research |
Online Access: | https://doi.org/10.52965/001c.36074 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive review
by: Elyse M. Cornett, et al.
Published: (2022-10-01) -
Cost-Effectiveness of Apomorphine Sublingual Film as an “On-Demand” Treatment for “OFF” Episodes in Patients with Parkinson's Disease
by: Andrew Thach, et al.
Published: (2021-11-01) -
pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy
by: Noeen Sarfraz, et al.
Published: (2022-05-01) -
Rimegepant for the treatment of migraine
by: Amnon A. Berger, et al.
Published: (2022-10-01) -
Phenothiazines and their Evolving Roles in Clinical Practice: A Narrative Review
by: Amber N. Edinoff, et al.
Published: (2022-11-01)